209 related articles for article (PubMed ID: 9893908)
1. Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer.
Setälä LP; Nordling S; Kosma VM; Lipponen PK; Eskelinen MJ; Hollmén SM; Syrjänen KJ; Alhava EM
Anal Quant Cytol Histol; 1997 Dec; 19(6):524-32. PubMed ID: 9893908
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.
Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G
Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448
[TBL] [Abstract][Full Text] [Related]
3. Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer.
Victorzon M; Roberts PJ; Haglund C; von Boguslawsky K; Nordling S
Anticancer Res; 1997; 17(4B):2923-6. PubMed ID: 9329565
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
5. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.
Victorzon M; Roberts PJ; Haglund C; von Boguslawsky K; Nordling S
Oncology; 1996; 53(3):182-91. PubMed ID: 8643219
[TBL] [Abstract][Full Text] [Related]
6. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study.
Russo A; Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Latteri F; Valerio MR; Pantuso G; Morello V; Dardanoni G; Latteri MA; Colucci G; Tomasino RM; Gebbia N
Cancer; 2001 Jul; 92(2):294-302. PubMed ID: 11466682
[TBL] [Abstract][Full Text] [Related]
7. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
[TBL] [Abstract][Full Text] [Related]
9. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy: a prognostic factor of response to chemotherapy and survival in metastatic gastric adenocarcinoma.
Syrios J; Kechagias G; Agrogiannis G; Xynos ID; Kavantzas N; Lazaris AC; Amptoulach S; Mourati A; Sougioultzis S; Patsouris ES; Tsavaris N
Anticancer Res; 2013 Mar; 33(3):1209-14. PubMed ID: 23482804
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers.
Ohyama S; Yonemura Y; Miyazaki I
Cancer; 1990 Jan; 65(1):116-21. PubMed ID: 2293858
[TBL] [Abstract][Full Text] [Related]
12. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis.
Esteban F; de Vega DS; Garcia R; Rodriguez R; Manzanares J; Almeida A; Tamames S
Hepatogastroenterology; 1999; 46(27):2039-43. PubMed ID: 10430394
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
[TBL] [Abstract][Full Text] [Related]
14. Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer.
Pinto AE; Mendonça E; André S; Nóbrega SD; Soares J
Anal Quant Cytol Histol; 2002 Dec; 24(6):345-54. PubMed ID: 12508694
[TBL] [Abstract][Full Text] [Related]
15. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
[TBL] [Abstract][Full Text] [Related]
18. Gastric lymphomas in Turkey. Analysis of prognostic factors with special emphasis on flow cytometric DNA content.
Aydin ZD; Barista I; Canpinar H; Sungur A; Tekuzman G
Cancer; 2000 Jul; 89(1):12-20. PubMed ID: 10896995
[TBL] [Abstract][Full Text] [Related]
19. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
20. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]